United States Biotechnology & Medical Research

CalciMedica Inc (CALC)

Track

CalciMedica Inc. recorded one significant insider trading transaction over the past ninety days, involving a purchase valued at approximately 200,000 dollars. This activity follows a period of positive stock performance and a notable earnings report beat. No selling activity occurred during this timeframe, reflecting recent internal confidence regarding the firm's market trajectory.
Ticker: CALC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for CalciMedica Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 25 Jun 2026
Value US$2,241,404.90 | Price 220.61 | Shares 23,190 (-15.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-29 2026-06-25 B Purchase
2.6
Middleton Fred A
Non-Executive Director Large shareholder
23,190 -15.6%
220.61
US$2,241,405 		23,190 -15.6% 220.61 US$2,241,405
2025-09-22 2025-09-18 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
92,980 +21.0%
143.06
US$2,248,589 		92,980 +21.0% 143.06 US$2,248,589
2025-09-17 2025-09-15 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
27,868 +41.4%
120.09
US$4,615,044 		27,868 +41.4% 120.09 US$4,615,044
2025-09-15 2025-09-12 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,000 +6.8%
3.12
US$15,600 		5,000 +6.8% 3.12 US$15,600
2025-09-11 2025-09-09 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
2,343 +3.3%
3.15
US$7,378 		2,343 +3.3% 3.15 US$7,378
2025-09-02 2025-08-29 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
800 +1.1%
2.74
US$2,192 		800 +1.1% 2.74 US$2,192
2025-09-02 2025-08-28 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
9,200 +15.1%
2.86
US$26,340 		9,200 +15.1% 2.86 US$26,340
2025-08-25 2025-08-21 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
3,508 +6.1%
2.79
US$9,797 		3,508 +6.1% 2.79 US$9,797
2025-08-21 2025-08-20 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
2,000 +3.6%
2.72
US$5,440 		2,000 +3.6% 2.72 US$5,440
2025-08-21 2025-08-19 B Purchase
4.2
Hebbar Sudarshan

Chief Medical Officer

Officer
9,563 +18.4%
2.82
US$26,962 		9,563 +18.4% 2.82 US$26,962
2025-08-21 2025-08-19 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
1,000 +1.8%
2.79
US$2,790 		1,000 +1.8% 2.79 US$2,790
2025-08-19 2025-08-15 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,076 +10.3%
2.90
US$14,709 		5,076 +10.3% 2.90 US$14,709
2025-08-18 2025-08-15 B Purchase
4.2
Hebbar Sudarshan

Chief Medical Officer

Officer
4,392 +9.2%
2.79
US$12,267 		4,392 +9.2% 2.79 US$12,267
2025-08-18 2025-08-14 B Purchase
4.2
Hebbar Sudarshan

Chief Medical Officer

Officer
1,584 +3.4%
2.59
US$4,095 		1,584 +3.4% 2.59 US$4,095
2025-07-29 2025-07-28 B Purchase
2.8
Stauderman Kenneth A.

Chief Scientific Officer

Officer
1,000 +8.4%
3.96
US$3,960 		1,000 +8.4% 3.96 US$3,960
2025-07-29 2025-07-25 S Sale
2.8
Stauderman Kenneth A.

Chief Scientific Officer

Officer
1,000 -100.0%
3.65
US$3,650 		1,000 -100.0% 3.65 US$3,650
2025-07-23 2025-07-22 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
1,500 +3.1%
3.78
US$5,662 		1,500 +3.1% 3.78 US$5,662
2025-07-22 2025-07-21 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
1,500 +3.2%
3.37
US$5,055 		1,500 +3.2% 3.37 US$5,055
2025-07-21 2025-07-21 B Purchase
2.4
Leheny A. Rachel

CHIEF EXECUTIVE OFFICER

Executive Director Large shareholder
1,000 +40.0%
3.40
US$3,400 		1,000 +40.0% 3.40 US$3,400
2025-07-18 2025-07-18 B Purchase
2.9
WILSON ROBERT N
Non-Executive Director
4,500 +1.1%
2.87
US$12,915 		4,500 +1.1% 2.87 US$12,915
2025-07-18 2025-07-18 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
2,000 +4.5%
2.88
US$5,760 		2,000 +4.5% 2.88 US$5,760
2025-07-16 2025-07-14 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
6,500 +17.2%
2.43
US$15,810 		6,500 +17.2% 2.43 US$15,810
2025-07-15 2025-07-14 B Purchase
2.4
Leheny A. Rachel

CHIEF EXECUTIVE OFFICER

Executive Director Large shareholder
2,500 +inf%
2.47
US$6,175 		2,500 +inf% 2.47 US$6,175
2025-07-10 2025-07-09 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,000 +15.2%
1.60
US$8,024 		5,000 +15.2% 1.60 US$8,024
2025-07-02 2025-07-01 B Purchase
2.8
Stauderman Kenneth A.

Chief Scientific Officer

Officer
1,000 +inf%
1.85
US$1,850 		1,000 +inf% 1.85 US$1,850
2025-06-27 2025-06-26 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
4,500 +15.9%
1.44
US$6,483 		4,500 +15.9% 1.44 US$6,483
2025-06-26 2025-06-26 B Purchase
3.6
Bardin Stephen

Chief Financial Officer

Officer
2,000 +200.0%
1.50
US$3,005 		2,000 +200.0% 1.50 US$3,005
2025-06-13 2025-06-11 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,000 +21.4%
1.85
US$9,250 		5,000 +21.4% 1.85 US$9,250
2025-06-09 2025-06-06 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,000 +27.3%
1.78
US$8,875 		5,000 +27.3% 1.78 US$8,875
2025-06-09 2025-06-05 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,100 +38.6%
1.70
US$8,670 		5,100 +38.6% 1.70 US$8,670
2025-06-03 2025-05-30 B Purchase
3.6
Bardin Stephen

Chief Financial Officer

Officer
1,000 +2.5%
1.69
US$1,690 		1,000 +2.5% 1.69 US$1,690
2024-12-06 2024-12-06 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
4,800 +15.1%
2.65
US$12,720 		4,800 +15.1% 2.65 US$12,720
2024-11-05 2024-11-01 B Purchase
0.6
Sanderling Venture Partners VI Co Investment Fund LP
Large shareholder
877 +4.1%
3.75
US$3,289 		877 +4.1% 3.75 US$3,289
2024-11-05 2024-11-01 B Purchase
0.6
Sanderling Venture Partners VI Co Investment Fund LP
Large shareholder
86,867 +11.9%
3.75
US$325,751 		86,867 +11.9% 3.75 US$325,751
2024-11-05 2024-11-01 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
877 +4.1%
3.75
US$3,289 		877 +4.1% 3.75 US$3,289
2024-11-05 2024-11-01 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
86,867 +11.9%
3.75
US$325,751 		86,867 +11.9% 3.75 US$325,751
2024-11-05 2024-11-01 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
20,000 +170.7%
3.75
US$75,000 		20,000 +170.7% 3.75 US$75,000
2024-11-01 2024-11-01 B Purchase
2.4
Leheny A. Rachel

CHIEF EXECUTIVE OFFICER

Executive Director Large shareholder
20,000 +18.0%
3.75
US$75,000 		20,000 +18.0% 3.75 US$75,000
2024-11-01 2024-11-01 B Purchase
2.9
WILSON ROBERT N
Non-Executive Director
53,333 +14.6%
3.75
US$199,999 		53,333 +14.6% 3.75 US$199,999
2024-11-01 2024-11-01 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
53,333 +47.9%
3.75
US$199,999 		53,333 +47.9% 3.75 US$199,999
2024-08-27 2024-08-27 B Purchase
2.4
Leheny A. Rachel

CHIEF EXECUTIVE OFFICER

Executive Director Large shareholder
1,000 +0.9%
4.19
US$4,190 		1,000 +0.9% 4.19 US$4,190
2024-08-26 2024-08-23 B Purchase
2.9
WILSON ROBERT N
Non-Executive Director
54,000 +17.4%
3.72
US$200,826 		54,000 +17.4% 3.72 US$200,826
2024-08-26 2024-08-23 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
3,000 +29.3%
3.57
US$10,710 		3,000 +29.3% 3.57 US$10,710
2024-08-26 2024-08-23 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
2,000 +4.5%
3.58
US$7,157 		2,000 +4.5% 3.58 US$7,157
2024-08-22 2024-08-21 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,000 +12.5%
4.04
US$20,200 		5,000 +12.5% 4.04 US$20,200
2024-07-02 2024-06-28 B Purchase
2.9
WILSON ROBERT N
Non-Executive Director
51,278 +19.8%
3.52
US$180,499 		51,278 +19.8% 3.52 US$180,499
2024-07-01 2024-06-27 B Purchase
2.9
WILSON ROBERT N
Non-Executive Director
8,443 +3.4%
3.23
US$27,305 		8,443 +3.4% 3.23 US$27,305
2024-06-28 2024-06-27 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
5,000 +95.7%
3.22
US$16,100 		5,000 +95.7% 3.22 US$16,100
2024-04-02 2024-04-02 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
3,254 +8.9%
3.90
US$12,691 		3,254 +8.9% 3.90 US$12,691
2024-04-02 2024-04-01 B Purchase
3.7
Roberts Eric W

CHIEF BUSINESS OFFICER

Executive Director Large shareholder
746 +2.1%
3.90
US$2,909 		746 +2.1% 3.90 US$2,909
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
28,744 +1856.8%
3.70
US$106,410 		28,744 +1856.8% 3.70 US$106,410
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
3,920 +22.2%
3.70
US$14,512 		3,920 +22.2% 3.70 US$14,512
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
13,184 +91.4%
3.70
US$48,807 		13,184 +91.4% 3.70 US$48,807
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
51,032 +80.7%
3.70
US$188,920 		51,032 +80.7% 3.70 US$188,920
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
194,472 +80.8%
3.70
US$719,935 		194,472 +80.8% 3.70 US$719,935
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
144,676 +24.8%
3.70
US$535,591 		144,676 +24.8% 3.70 US$535,591
2024-01-25 2024-01-23 B Purchase
2.6
MIDDLETON FRED A
Non-Executive Director Large shareholder
243,356 +34.6%
3.70
US$900,904 		243,356 +34.6% 3.70 US$900,904
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
28,744 +1856.8%
3.70
US$106,410 		28,744 +1856.8% 3.70 US$106,410
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
3,920 +22.2%
3.70
US$14,512 		3,920 +22.2% 3.70 US$14,512
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
13,184 +91.4%
3.70
US$48,807 		13,184 +91.4% 3.70 US$48,807
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
51,032 +80.7%
3.70
US$188,920 		51,032 +80.7% 3.70 US$188,920
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
194,472 +80.8%
3.70
US$719,935 		194,472 +80.8% 3.70 US$719,935
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
144,676 +24.8%
3.70
US$535,591 		144,676 +24.8% 3.70 US$535,591
2024-01-25 2024-01-23 B Purchase
Sanderling Venture Partners VI LP
Large shareholder
243,356 +34.6%
3.70
US$900,904 		243,356 +34.6% 3.70 US$900,904
2023-12-13 2023-12-11 B Purchase
2.9
WILSON ROBERT N
Non-Executive Director
506 +0.3%
3.30
US$1,670 		506 +0.3% 3.30 US$1,670
2023-11-08 2023-11-07 B Purchase
2.4
Leheny A. Rachel

Chief Executive Officer

Executive Director Large shareholder
2,000 +11.9%
3.34
US$6,680 		2,000 +11.9% 3.34 US$6,680
2023-11-08 2023-11-06 B Purchase
3.7
Roberts Eric W

Chief Business Officer

Executive Director Large shareholder
2,400 +7.2%
3.12
US$7,488 		2,400 +7.2% 3.12 US$7,488
2023-11-07 2023-11-06 B Purchase
2.4
Leheny A. Rachel

Chief Executive Officer

Executive Director Large shareholder
2,440 +16.9%
3.12
US$7,615 		2,440 +16.9% 3.12 US$7,615
2023-11-07 2023-11-03 B Purchase
4.2
Hebbar Sudarshan

Chief Medical Officer

Officer
36,000 +360.0%
2.74
US$98,600 		36,000 +360.0% 2.74 US$98,600
2023-11-07 2023-11-03 B Purchase
3.7
Roberts Eric W

Chief Business Officer

Executive Director Large shareholder
11,249 +50.6%
2.83
US$31,846 		11,249 +50.6% 2.83 US$31,846
2023-11-07 2023-11-03 B Purchase
3.7
Roberts Eric W

Chief Business Officer

Executive Director Large shareholder
3,700 +22.3%
2.77
US$10,249 		3,700 +22.3% 2.77 US$10,249
2023-11-06 2023-11-03 B Purchase
2.4
Leheny A. Rachel

Chief Executive Officer

Executive Director Large shareholder
5,000 +53.2%
2.85
US$14,250 		5,000 +53.2% 2.85 US$14,250
2023-11-06 2023-11-03 B Purchase
3.7
Roberts Eric W

Chief Business Officer

Executive Director Large shareholder
5,860 +35.8%
2.70
US$15,828 		5,860 +35.8% 2.70 US$15,828
2023-11-06 2023-11-03 B Purchase
3.7
Roberts Eric W

Chief Business Officer

Executive Director Large shareholder
3,200 +23.9%
2.80
US$8,960 		3,200 +23.9% 2.80 US$8,960
2023-08-29 2023-08-25 B Purchase
3.7
Roberts Eric W

Chief Business Officer

Executive Director Large shareholder
736 +17.3%
3.18
US$2,340 		736 +17.3% 3.18 US$2,340
Explore more

More insider trading research around CalciMedica Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America